B Acute Lymphoblastic Leukemia — Trials

B Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

345 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 151
Recruiting: 94
Ph III recruiting: 11
Growth YoY: +11.1%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 45.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02003222	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia	active not recruiting	Phase 3	488	National Cancer Institute (NCI)NIH	4	Sep 21, 2026	clinicaltrials
NCT05602194	Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma	active not recruiting	Phase 3	440	Children's Oncology GroupNETWORK	2	Aug 21, 2026